Breast cancer death rates have stopped going down, reports research Dr. Kamal Kant Kohli7 March 2025 8:15 PM ISTA new paper in the Journal of Breast Imaging, published by Oxford University Press, indicates that breast cancer mortality rates have stopped...
Higher Maternal BMI in Pregnancy Associated with Childhood Acute Lymphoblastic Leukemia Risk in Daughters: Study Medha Baranwal6 March 2025 8:45 PM ISTGermany: A recent study published in the Leukemia Journal suggests that higher maternal body mass index (BMI) during pregnancy may increase the risk...
Tattoos may be linked to increased risk of cancer, reveals research Dr. Kamal Kant Kohli6 March 2025 8:45 PM ISTPeople often put a lot of thought into getting a tattoo. But there's one thing most people forget to think about-what impact the tattoo might have on...
Genetic Drivers of Aggressive Prostate Cancer, Study Reveals Dr. Bhumika Maikhuri6 March 2025 8:30 AM ISTScientists from UCLA, the University of Toronto and the University of Melbourne have uncovered new genetic clues that explain why some prostate...
Study Reveals Breakthrough Discovery: How Cancer Outsmarts the Immune System Dr. Bhumika Maikhuri6 March 2025 8:15 AM ISTResearch into immunotherapy against cancer typically focuses on better recognition of cancer cells by the body's own immune system. Researchers at...
Study uncovers how low-carb diet drives colorectal cancer development Dr. Kamal Kant Kohli5 March 2025 9:00 PM ISTResearchers from the University of Toronto have shown how a low-carbohydrate diet can worsen the DNA-damaging effects of some gut microbes to cause...
Breast-conserving surgery improves sexual well-being compared to breast reconstruction: Study Dr. Kamal Kant Kohli5 March 2025 8:30 PM ISTFor women with breast cancer, breast-conserving therapy (BCT) is associated with improved sexual well-being, compared to mastectomy followed by breast...
USFDA nod to Zydus Lifesciences cancer drug Dasatinib Ruchika Sharma5 March 2025 4:47 PM ISTAhmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to manufacture ...
Bayer begins Phase II trial with BAY 2927088 in metastatic or unresectable HER2 mutant solid tumors Ruchika Sharma5 March 2025 9:00 AM ISTBerlin: Bayer has announced that the first patient has been enrolled in the global Phase II panSOHO study, an open-label clinical trial,...
Common malaria drug repurposed to fight cancer, reports research Dr. Kamal Kant Kohli4 March 2025 9:00 PM ISTCan a drug that's used to treat malaria be repurposed to fight cancer? Researchers at The University of Texas at El Paso have secured a patent for the...
AstraZeneca-Daiichi Sankyo Enhertu recommended for approval in EU for patients with HER2-low or HER2-ultralow metastatic breast cancer Ruchika Sharma3 March 2025 12:15 PM ISTCambridge: AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has been recommended for approval in the European Union...
Metabolic Syndrome independently associated with increased susceptibility to renal cell carcinoma, finds study Dr. Shravani Dali2 March 2025 8:15 PM ISTMetabolic Syndrome independently associated with increased susceptibility to renal cell carcinoma, finds study published in the BMC...
